Complex group name | MLL |
Complex name | CHD8 |
Genes in complex | ASH2L#43, C17orf49#94?, CHD8#139, DPY30#189, E2F6#193?, HCFC1#257?, HCFC2#258?, (HSPA1A#294|HSPA1B#296)?, INO80C#309?, KANSL1#320?, KAT8#329?, KDM6A#345?, KMT2A#352, LAS1L#361?, MAX#369?, MCRS1#381?, MEN1#385?, MGA#392?, NCOA6#431?, PAGR1#458?, PAXIP1#464?, PELP1#474?, PHF20#485?, PRPF31#532?, RBBP5#548, RNF2#572?, RUVBL1#584?, RUVBL2#585?, SENP3#599?, TAF1#678?, TAF4#684?, TAF6#687?, TAF7#689?, TAF9#691?, TEX10#701?, WDR5#764 |
Alternative names | MLL1/MLL, CHD8 |
Proteins involved | ASH2L, RBBP5, WDR5, DPY30, MLL and the facultative components PAGR1, BAP18, CHD8, E2F6, HCFC1, HCFC2, HSP70, INO80C, KDM6A, KANSL1, LAS1L, MAX, MCRS1, MEN1, MGA, KAT8/MOF, NCOA6, PAXIP1/PTIP, PELP1, PHF20, PRP31, RING2, RUVB1/TIP49A, RUVB2/TIP49B, SENP3, TAF1, TAF4, TAF6, TAF7, TAF9, TEX10 and alpha- and beta-tubulin |
Uniprot IDs of involved proteins | ASH2L_HUMAN, BAP18_HUMAN?, CHD8_HUMAN, DPY30_HUMAN, E2F6_HUMAN?, HCFC1_HUMAN?, HCFC2_HUMAN?, HSP71_HUMAN?, IN80C_HUMAN?, KANL1_HUMAN?, KAT8_HUMAN?, KDM6A_HUMAN?, KMT2A_HUMAN, LAS1L_HUMAN?, MAX_HUMAN?, MCRS1_HUMAN?, MEN1_HUMAN?, MGAP_HUMAN?, NCOA6_HUMAN?, PAGR1_HUMAN?, PAXI1_HUMAN?, PELP1_HUMAN?, PHF20_HUMAN?, PRP31_HUMAN?, RBBP5_HUMAN, RING2_HUMAN?, RUVB1_HUMAN?, RUVB2_HUMAN?, SENP3_HUMAN?, TAF1_HUMAN?, TAF4_HUMAN?, TAF6_HUMAN?, TAF7_HUMAN?, TAF9_HUMAN?, TEX10_HUMAN?, WDR5_HUMAN |
PMID for reference on complex composition | PMID:15960975, PMID:22108599 |
Function | histone methylation complex, histone acetylation complex |
PMID for reference on function | PMID:19556245 |
Target molecule type | histone |
Specific target | H3K4, H4K16 |
Product | H3K4me, H4K16ac |
Target UniProt ID | H31_HUMAN, H31T_HUMAN, H32_HUMAN, H33_HUMAN, H3C_HUMAN, H4_HUMAN |
PMID for reference on targets and products | PMID:19556245 |
Comment | A multiprotein complex that mediates both methylation of 'Lys-4' of histone H3 (H3K4me) complex and acetylation of 'Lys-16' of histone H4 (H4K16ac). |
Status of entry | # |